Amy Gibson

Dr. Amy Gibson is a Senior Research Officer at the National Drug and Alcohol Research Centre, UNSW Australia, with expertise in epidemiology, public health, and health data science. She holds a PhD in Public Health from UNSW (2009), a Master of Public Health from the University of Sydney (2004), and dual bachelor's degrees in Biomedical Science and Arts from UNSW (2000).

• Doctor of Philosophy, School of Public Health and Community Medicine, UNSW (2009)
• Masters of Public Health, University of Sydney (2004)
• Bachelor of Science (Biomedical Science), Honours in Pharmacology, UNSW (2000)
• Bachelor of Arts (Sociology), UNSW (2000)

Her research focuses on opioid dependence, mortality, and treatment outcomes using linked data. She has developed and taught postgraduate courses like Context of Health Data Science and Foundations of Epidemiology, and contributed to cloud-based research infrastructure and government stakeholder collaborations.

Recent publications (2025) analyze opioid agonist treatment efficacy, severe mental illness impacts on mortality, and data linkage methods. Earlier works (2015-2011) examine buprenorphine/methadone retention, prison mortality, and liver disease comorbidities among opioid-dependent populations.

• Award for Excellence in Educational Design or Development (2018)
• UNSW Faculty of Medicine Dean's List (2009)
• National Drug and Alcohol Research Centre PhD Scholarship (2005-2008)
• UNSW Honours Scholarship (1999)

She has coordinated major training contracts with the Australian Government Department of Health and secured NHMRC project grants for opioid substitution therapy research. Her work bridges academic research, government policy, and postgraduate education in health data science.